Clinical Briefings™: Identifying Risk Factors and Improving Quality of Life in Dry Eye Disease

Release Date: February 12, 2020
Expiration Date: February 12, 2021
Media: Internet - based

Activity Overview

Dry eye disease (DED) is a common condition in the general public, with particular prevalence among patients who wear contact lenses and those seeking treatment for cataracts. A variety of screening and diagnostic tools are available for eye care professionals to identify DED, and a range of over-the-counter treatments, prescription medications, and devices have demonstrated therapeutic efficacy. This educational program provides a high-level overview of recent guidelines covering DED diagnosis and treatment for general populations and preoperative patients, as well as expert perspective focusing on particular topics of interest for eye care professionals, such as choosing efficient point-of-care tests; evaluating patients for aqueous deficient, evaporative, and mixed features; and identifying ocular “masqueraders” that mimic DED.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Alcon and Novartis Pharmaceuticals Corporation.

Target Audience

This online educational activity is directed toward ophthalmologists and other health care professionals involved in dry eye disease care, such as PCPs, NPs and PAs.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

• Review risk factors associated with dry eye disease and their role in screening and early diagnosis in affected patients
• Evaluate clinical efficacy and safety data for current and emerging therapies for patients with dry eye
• Develop an individualized management plan to overcome patient barriers to care

Faculty, Staff, and Planners’ Disclosures

Faculty

Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Vice-President/President-Elect, American Society of Cataract and Refractive Surgery (ASCRS)
Duke University Eye Center
Durham, NC

Disclosures: Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Avedro, Avellino Labs, Bausch & Lomb, BlephEx, CorneaGen, Dompé, Eyenovia, Johnson & Johnson, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Novartis, Ocular Therapeutix, Omeros, Presbyopia Therapies, Shire, Sight Sciences, Simple Contacts, Surface, Zeiss; Stock/Shareholder: Avellino Labs, CorneaGen, Eyenovia, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Ocular Therapeutix, Omeros, Presbyopia Therapies, Simple Contacts

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER^® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER^® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER^® is required by ACCME to resolve all COI. PER^® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or the company that provided commercial support.